AVP
Also known as Atlantic Vantage Point, AXA Venture Partners, AVP Capital
Paris-headquartered, AMF-authorised transatlantic tech investor (ex-AXA Venture Partners, launched 2016); venture, early-growth, growth and fund-of-funds strategies, €1M–€150M checks.
Formerly AXA Venture Partners; independent since the 2024–2025 management buyout. Not to be confused with CAVP (pharmacists’ pension fund).
- HEADQUARTERS
- Paris, France
- FOUNDED
- 2016
- OUTSIDE CAPITAL
- Yes
- TEAM LISTED
- 10 people
FOCUS
- STAGES
- Series ASeries BGrowth
- ASSET MIX
- Venture capitalFunds (as LP)
- GEOGRAPHY
- EuropeNorth America
WHAT IT IS
VC Fund. A fund manager investing capital raised from limited partners into startups.
ABOUT
AVP (Atlantic Vantage Point) is a multi-stage technology investment platform with offices in Paris, London and New York, launched in 2016 as AXA Venture Partners. AXA’s 70% stake was bought by the management team after AXA agreed to sell AXA Investment Managers to BNP Paribas; the firm rebranded and became independent in April 2025, with AXA remaining a strategic partner. It invests through venture (€1–10M), early-growth (€10–40M) and growth (€40–150M) strategies in enterprise software, fintech/insurtech, digital health and consumer platforms in Europe and North America, and also invests in third-party VC funds. In June 2026 it launched E2D, a €500M European defence and dual-use growth fund with Earlybird.
INVESTMENT THESIS
Minority stakes with active engagement in capital-efficient tech companies in the U.S./Canada and Europe — enterprise software, fintech/insurtech, digital health and consumer platforms; venture (revenue < €8M, €1–10M checks), early growth (revenue > €8M, €10–40M), growth (revenue > €40M, €40–150M); E2D defence/dual-use growth deals of about €25M; fund investing in venture and growth funds, secondaries and co-investments.
PORTFOLIO (20)
- OdooNOTABLESoftware & SaaS
- AgicapNOTABLEFintech
- Alice & BobNOTABLEDeep Tech
- WhiteLab GenomicsBiotech & Life Sciences · since 2026
- DeepgramArtificial Intelligence
- QdrantArtificial Intelligence
- SecurityScorecardSoftware & SaaS
- PhenomSoftware & SaaS
- FinomFintech
- FlatpayFintech
- MercanisSoftware & SaaS
- AbstractSoftware & SaaS
- LinqAlphaArtificial Intelligence
- IsometricArtificial Intelligence
- Defense UnicornsSoftware & SaaS
- CryptonextSoftware & SaaS
- SendcloudSoftware & SaaS
- CognismSoftware & SaaS
- PolicyGeniusFintech
- One IncFintech
TEAM
- François RobinetManaging Partner · source
- Manish AgarwalGeneral Partner (Venture) · source
- Benoit FosseprezGeneral Partner (Early growth; European Defense) · source
- Alex ScherbakovskyGeneral Partner (Early growth) · source
- Elizabeth de Saint-AignanGeneral Partner (Growth) · source
- Warda ShaheenGeneral Partner (Growth) · source
- Marc LewdenPartner – Chief Operating Officer · source
- Sébastien LoubryPartner – Business Development · source
- Stéphanie VervoitteFundraising Director · source
- Céline CosculluelaHead of Compliance · source
LINKS
FAQ
AVP is a VC fund based in Paris, France, founded in 2016.
Yes. AVP invests directly in private companies. It also commits capital to third-party funds as an LP.
AVP invests at Series A, Series B and Growth stages in Software & SaaS, Fintech, HealthTech, Artificial Intelligence, Consumer & E-commerce and Deep Tech.
AVP's stated ticket size is €1M–€150M.
Key people at AVP include François Robinet (Managing Partner), Manish Agarwal (General Partner (Venture)), Benoit Fosseprez (General Partner (Early growth; European Defense)) and Alex Scherbakovsky (General Partner (Early growth)).
AVP's investments include Odoo, Agicap, Alice & Bob, WhiteLab Genomics, Deepgram, Qdrant, SecurityScorecard and Phenom, among others.
The most recent publicly reported investment by AVP is WhiteLab Genomics ($26M Series B (led by AVP)), announced in Oct 2026.
AVP states that it accepts submissions through its official contact page.
Yes. AVP manages capital from outside investors.